Meeting Title: 26th Annual Scientific Sessions: Changing Global Clinical Practice
Recorded Sessions from SCRM Meeting January 25-28, 2023
Format (Enduring Material)
Activity Expiration: August 1st, 2023
Acknowledgement of Financial Commercial Support
The following company provided monetary support for this CME educational activity in the form of an unrestricted educational grant: AstraZeneca
Acknowledgement of In-Kind Support
No in-kind support was received for this educational activity.
Accreditation Statement
The Society of Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
SCMR designates this enduring material activity for a maximum of 80.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
80.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit. By providing your information you grant SCMR permission to report your CME/MOC hours to the ACCME and/or other boards as applicable.
American Board of Internal Medicine (ABIM) MOC:
The activity is directly or jointly provided by an organization accredited in good standing within the ACCME System. The activity is planned in the context of one or more of the ABMS/ACGME competencies.
All CME sessions are eligible for ABIM MOC credit. On the post activity evaluation, learners can indicate if they want to have credits posted in the ACCME PARS system for awarded MOC credit.
American Board of Pediatrics (ABP) MOC:
Session that run during the general conference (not pre-conference) in the Pediatrics/Congenital Track (listed below) are eligible to earn APB MOC Credit. On the post activity evaluation, learners can indicate if they want to have credits posted in the ACCME PARS system for awarded MOC credit. For satisfactory completion to earn credit, if you check the box for ABP MOC credit, you will receive a link to complete a post test for each session you indicate that you attended. You must pass each posttest with a threshold of 75%. Quizzes can be retaken up to three times to achieve the threshold. MOC credit is issued based on the number of successfully passed quizzes.
|
Value of Artificial Intelligence in Congenital Heart Disease CMR |
|
CMR for the End-User in Pediatric and Congenital CMR |
|
Fetal CMR |
|
3D+ Printing in Pediatric and Congenital Heart Disease |
|
Contrast agents in Pediatric and Congenital Heart Disease - the Great Debate |
Satisfactory Completion/CME/MOC
To claim credit for a live SCMR CME event, you must complete the credit claim and evaluation. CME certificates will be provided upon completion. You will be able to send a copy of the certificate to yourself as an e-mail attachment. All registered participants will receive an email with information on how to claim credit.
If you need assistance with accessing the meeting evaluation systems, please contact kerim@veritasamc.com or via email at info@scmr.org.
Educational Information
Physician Practice Gap:
New advanced technology for CMR is being developed rapidly and research is demonstrating the clinical utility of CMR for multiple cardiac pathologies. There is slow uptake of the new applications and techniques, and communication of ongoing research. Training gaps have widened for physicians in practice regarding knowledge of these new techniques and how to use them clinically. The ideal future state is that we would have a more educated CMR imaging workforce both in terms of technical development and clinical applications that are rapidly translated into clinical practice to optimize clinical care.
Needs that Underlie the Gap
DESIGNED to Change/Outcome: Following this activity, learners will develop competence in using the latest cutting-edge research and clinical application of cardiovascular magnetic resonance imaging and will report their intentions to apply concepts and implement new techniques into their practice in the post-activity evaluation. Later in the year, learners may be invited to share how their practice changed as a result of the education provided and if they have observed any patient outcome changes as a result.
OFF LABEL/INVESTIGATIONAL DISCUSSION
The following faculty have indicated that they will be discussing unlabeled/investigational uses of medical devices or pharmaceuticals.
|
Last Name |
First Name |
Off Label Disclosure(s) |
Presentation |
|
Campbell |
Michael |
Gadolinium (Manufacturer: Off-label use: Cardiac Imaging) |
Pediatrics/Congenital Session 1: The Great Contrast Debate |
|
Coelho-Filho |
Otavio |
Gadolinium-based contrast agents (Manufacturer: Several manufactures, Off-label use: cardiovascular magnetic resonance imaging) |
Read with the Experts #3 – Cardiomyopathies |
|
Finn |
John |
Ferumoxytol (Manufacturer: Covis Pharma and Sandoz Pharma, Off-label use: diagnostic MRI) |
Talk 4. Q&A /Panel discussion |
|
Hsiao |
Albert |
All commercial strain imaging products (Manufacturer: all commercial softwares, Off-label use: measurement of myocardial strain) |
Talk 3 - Strain Imaging: Comparison Of Techniques And Clinical Applications |
|
Kim |
Raymond |
Gadolinium contrast (Manufacturer: No specific manufacturer, Off-label use: gadolinium contrast for imaging the heart) |
Talk #2 - Debate: Viability Imaging is Still Alive after STITCH and REVIVED (Pro) |
|
Litt |
Harold |
Gadolinium contrast agents (Manufacturer: multiple, Off-label use: cardiac MRI) Non MRI-conditional cardiac devices (Manufacturer: , Off-label use: Performing MRI) |
Talk #1 - Are any implantable cardiac devices unsafe to image today? |
|
Neubauer |
Stefan |
Metabolic modulators (Manufacturer: general description of the concept, Off-label use: heart failure) |
The Hypertrophic Cardiomyopathy Registry (HCMR) study - Update on event accrual and ancillary studies, Talk #3 - MRI evaluation of metabolism in heart-failure.
|
|
Patel |
Amit |
REGADENOSON (Manufacturer: ASTELLAS, Off-label use: STRESS MRI) |
Talk #3 - Evidence Supporting Stress CMR and New Developments, Talk 3 - Quantification Of Myocardial Perfusion, Talk 3 - Quantification Of Myocardial Perfusion |
|
Simonetti |
Orlando |
Siemens MAGNETOM Free. Max (Manufacturer: Siemens, Off-label use: Cardiac MRI) |
The SCMR Registry: Big Data Research Opportunities, |
|
Sinusas |
Albert |
RP805 (Manufacturer: MicroVide, LLC, Off-label use: research) |
T2 Mapping in Acute Infarct Characterization at 0.55 T, Opportunities for CMR to Change Global Clinical Practice |
|
Zimmerman |
Stefan |
Gadolinium (Manufacturer: various, Off-label use: Cardiac MRI) |
Talk 1 - New insights in Arrhythmogenic Cardiomyopathy |
|
Nugent |
Alan |
Balloon wedge catheter (Manufacturer: Arrow, Edwards, Off-label use: Catheter used in MRI) |
iCMR-Pre1 – Clinical |
|
Amin |
Elena |
balloon wedge catheter (Manufacturer: Arrow, Off-label use: iCMR)|gadolinium (Manufacturer: N/A, Off-label use: to fill balloon of balloon wedge catheter for iCMR) |
Pediatrics/Congenital Session 2: CMR for the End-User |
|
Ghosh |
Reena |
Ferumoxytol (Feraheme) (Manufacturer: Amag Pharmaceuticals, Off-label use: MRI contrast agent) |
Pediatrics/Congenital Session 3: SIG3D+ Printing/Peds |
|
Oechtering |
Thekla |
Ferumoxytol (Manufacturer: , Off-label use: MRI contrast agent) |
Joint-Session with SMRA |
|
Maskatia |
Shiraz |
Ferumoxytol (Manufacturer: AMAG pharmaceutical, Off-label use: Cardiovascular imaging contrast agent) |
Pediatrics/Congenital Session 1: The Great Contrast Debate |
|
Biko |
David |
Ferumoxytol (Manufacturer: AMAG Pharmaceuticals, Inc, Off-label use: MRI Contrast Agent) |
Peds/CHD Pre Conference - Session 5 Controversies in Pediatric and Congenital CMR |
|
Dawson |
Dana |
Ferumoxytol (Manufacturer: AMAG Pharmaceuticals, Off-label use: myocardial inflammation)|Fast Field Cycling MRI (Manufacturer: University of Aberdeen, Off-label use: cardiac imaging) |
Early Career: Professional Growth in CMR – Research - Session 2 |
|
Balasubramanian |
Sowmya |
Gadolinium (Manufacturer: , Off-label use: Pediatric population) |
Peds/CHD Pre Conference - Session 4 Single Ventricles: CMR From Infancy to Adulthood |
|
Hussain |
Tarique |
Gadolinium (Manufacturer: Bayer, Off-label use: Cardiac MRi in children)|Ferumoxytol (Manufacturer: AMAG Pharmaceuticals, Off-label use: Cardiac MRi in children) |
Pediatrics/Congenital Session 1: The Great Contrast Debate |
|
Fogel |
Mark |
Gadolinium (Manufacturer: Bayer, Off-label use: Congenial heart disease)|Ferumoxytol (Manufacturer: Zzzz, Off-label use: MRI) |
Physicians Pre-Conference 7 - Congenital and Structural |
|
Lawton |
Benny |
Gadolinium (Manufacturer: Bayer, Off-label use: Contrast) |
Technologist Track - Session 5. How I Do It: CMR the Future |
|
Greil |
Gerald |
Gadolinium (Manufacturer: Several companies, Off-label use: Vascular imaging)|Ferumoxytol (Manufacturer: Several companies, Off-label use: Vascular imaging) |
Peds/CHD Pre Conference - Session 3 Advanced Techniques |
|
Grizzard |
John |
Gadolinium based contrast (Manufacturer: Variety-- Bracco, Off-label use: cardovascular MR late gadolinium sequences) |
Oral Abstract Session Clinical #1 |
|
Samyn |
Margaret |
Gadolinium contrast (e.g. Gadavist) (Manufacturer: Bayer Healthcare Pharmaceutical and others, Off-label use: myocardial imaging) |
Peds/CHD Pre Conference - Session 4 Single Ventricles: CMR From Infancy to Adulthood |
|
Kotecha |
Tushar |
Gadolinium contrast (Manufacturer: Multiple, Off-label use: For cardiac MRI imaging) |
General CMR Session 5 – Quantitative Myocardial Perfusion CMR: Ready for Prime Time? |
|
Anwar |
Shafkat |
Gadolinium contrast agent (Manufacturer: Multiple manufacturers, Off-label use: contrast-enhanced MRA) |
Pediatrics/Congenital Session 3: SIG3D+ Printing/Peds |
|
Beroukhim |
Rebecca |
Gadolinium. (Manufacturer: , Off-label use: Pediatric CMR.) |
Physicians Pre-Conference 3 - Mapping Tissue Characterization |
|
Ferreira |
Vanessa |
Gadolinium-based contrast agents (GBCA) (Manufacturer: , Off-label use: Off-label) |
Early Career: Professional Growth in CMR – Research - Session 2 |
|
Töger |
Johannes |
Gd contrast agent (Manufacturer: Various, Off-label use: Cardiac MRI) |
General CMR Session #2 - CMR 4D Flow |
|
Campbell-Washburn |
Adrienne E |
Investigational MRI scanner (Manufacturer: Siemens, Off-label use: Research subjects imaging) |
ISMRM Workshop Session 4: Multinuclear Imaging and Spectroscopy |
|
Levelt |
Eylem |
Manganese (Manufacturer: University of Edinburgh, Off-label use: Research) |
ISMRM Workshop Parallel - Metabolic Clinical Trials and Metabolic Imaging |
|
Carlsson |
Marcus |
Pacemakers and ICD (Manufacturer: Many different, Off-label use: Some are off label in the MRI) |
Peds/CHD Pre Conference - Session 5 Controversies in Pediatric and Congenital CMR |
|
Salerno |
Michael |
gadolinium contrast (Manufacturer: Multiple Gd contrast Manufacturers, Off-label use: Cardiac MRI)
|
Talk 4 - Role of CMR in the multimodality assessment of cardiac sarcoidosis |
Disclosure of Financial Relationships
FACULTY DISCLOSURES
The following faculty have indicated that they do have financial relationships with ACCME defined ineligible companies within the past 24 months. All financial relationships have been mitigated. Those that have indicated an employee or ownership relationship (including privately held stock, royalty, intellectual property, etc.) with an ACCME defined ineligible have attested that the content of the presentations for which they are involved do not have anything to do with the product/services of those companies, that they will refrain from making care recommendations, and will avoid commercial bias in their role on each presentation.
All other faculty not listed below have indicated that they have no financial relationships to disclose.
|
Last Name |
First Name |
Presentation Role |
Financial Disclosures |
Method of Mitigation |
|
|
Ahmad |
Rizwan |
Moderator |
Siemens Healthineers: Funding through Master Research Agreement (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Allen |
Bradley |
Moderator |
Circle Cardiovascular Imaging: Consulting Fees (e.g., advisory boards) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Al-Mallah |
Mouaz |
Speaker |
Jubilant: Consulting Fees (e.g., advisory boards) (Ongoing)|Philips: Consulting Fees (e.g., advisory boards) (Terminated, August 31, 2021)|Siemens: Research grant (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Aneja |
Ashish |
Speaker |
Bristol Myers Squibb: Consulting Fees (e.g., advisory boards) (Ongoing)|Bristol Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Medtronic, Inc: Consulting Fees (e.g., advisory boards) (Ongoing)|Sanofi: Consulting Fees (e.g., advisory boards) (Ongoing)|Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Arai |
Andrew E. |
Speaker |
Bayer: Consulting Fees (e.g., advisory boards) (Ongoing)|Circle CVI: Consulting Fees (e.g., advisory boards) (Ongoing)|Circle CVI: Royalty (Ongoing)|Radcliffe: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 15, 2022) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Bairey Merz |
C Noel |
Moderator |
iRhythm: Consulting Fees (e.g., advisory boards) (Ongoing)|iRhythm: Board Director (Ongoing)|iRhythm: Stock-publicly held company (excluding mutual/index funds) (Ongoing)|SHL Telemedicine: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Bucciarelli-Ducci |
Chiara |
Speaker |
Bayer Healthcare: Consulting Fees (e.g., advisory boards) (Ongoing)|Bayer Healthcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Circle Cardiovascular Imaging: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Siemens Healtineers: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, August 11, 2021) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Burris |
Nicholas |
Moderator |
Imbio: Royalty (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Campbell |
Michael |
Panelist, Speaker |
Longeverone Inc: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Carr |
James |
Moderator, Speaker |
Bayer: Consulting Fees (e.g., advisory boards) (Ongoing)|Bayer: research (Ongoing)|Bracco: Consulting Fees (e.g., advisory boards) (Ongoing)| Guerbet: research (Ongoing)|Siemens: research (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Cavalcante |
Joao |
Moderator, Speaker, Planner |
Abbott Medical: Consulting Fees (e.g., advisory boards) (Ongoing)|Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)|Circle Cardiovascular Imaging: Research Support (Ongoing)|Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)|Medtronic, Inc: Consulting Fees (e.g., advisory boards) (Ongoing)|Siemens Healthineers: Research support (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Chan |
Frandics |
Panelist, Speaker |
GE Healthcare: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Chiribiri |
Amedeo |
Moderator |
GE Healthcare: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Coelho-Filho |
Otavio |
Speaker |
Astra Zeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing)|Astra Zeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Bayer Healtcare: Consulting Fees (e.g., advisory boards) (Ongoing)|Bayer Healtcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Boehringer Ingelheim: Consulting Fees (e.g., advisory boards) (Ongoing)|Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Novartis: Consulting Fees (e.g., advisory boards) (Ongoing)|Novartis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)|Novo Nordisk: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Pfizer: Consulting Fees (e.g., advisory boards) (Ongoing)|Pfizer: Research Grant (Ongoing)|Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Takeda: Consulting Fees (e.g., advisory boards) (Ongoing)|Takeda: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Contijoch |
Francisco |
Speaker |
GE Healthcare: Research Support (Terminated)|Siemens Healthcare: Research support (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Davies |
Rhodri |
Speaker |
Mycardium ai ltd: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Dharmakumar |
Rohan |
Speaker |
Cardio-Theranostics LLC: Equity (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Edelman |
Robert |
Speaker |
Siemens Healthcare: Royalty (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Ennis |
Daniel |
Moderator |
GE Healthcare: Research Funding (Only list those where you are the PI) |Siemens: Research funding (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Espe |
Emil |
Moderator |
Tenaya Therapeutics: Contracted research (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Finn |
John |
Speaker |
Bayer Pharma: Consulting Fees (e.g., advisory boards) (Ongoing)|Bracco Diagnostics: Consulting Fees (e.g., advisory boards) (Ongoing)|Covis Pharma: Consulting Fees (e.g., advisory boards) (Ongoing)|Siemens Healthineers: Research grant (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Fonseca |
Brian |
Moderator |
Siemens: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Fontana |
Marianna |
Speaker |
alexion: Consulting Fees (e.g., advisory boards) (Ongoing)|alexion: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Alnylam: Consulting Fees (e.g., advisory boards) (Ongoing)|Alnylam: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|attralus: Consulting Fees (e.g., advisory boards) (Ongoing)|bridgbio: Consulting Fees (e.g., advisory boards) (Ongoing)|intellia: Consulting Fees (e.g., advisory boards) (Ongoing)|Ionis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing)|Jannesn: Consulting Fees (e.g., advisory boards) (Ongoing)|Jannesn: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)|Novo Nordisk: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Pfizer: Consulting Fees (e.g., advisory boards) (Ongoing)|Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Friedrich |
Matthias |
Presenting Author, Speaker |
Circle Cardiovascular Imaging: Shareholder, Advisor (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Gordon |
Brent |
Moderator |
Abbott: Proctor (Ongoing)|WL Gore: Proctor/Speaker (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Greenwood |
John |
Moderator Presenting Author, Speaker |
Bayer Healthcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Edwards Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Gulati |
Martha |
Moderator, Speaker |
Siemens Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, August 30, 2022) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Hanneman |
Kate |
Moderator |
Amicus Therapeutics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)|Sanofi-Genzyme: Consulting Fees (e.g., advisory boards) (Ongoing)|Sanofi-Genzyme: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Hare |
James |
Moderator |
Bayer: Consulting Fees (e.g., advisory boards) (Terminated, October 1, 2022) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Hedström |
Erik |
Panelist, Presenting Author |
Bayer Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Heiberg |
Einar |
Panelist, Presenting Author, Speaker |
Medviso AB: Stock-privately held company |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Hsiao |
Albert |
Moderator, Speaker |
Arterys: Co-Founder, Shareholder (Terminated)|GE Healthcare: Research grants (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Hu |
Peng |
Moderator, Speaker |
United Imaging Healthcare: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Johnson |
Jason |
Moderator, Presenting Author |
Abbott Medical: Consulting Fees (e.g., advisory boards) |Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Judd |
Robert M. |
Moderator |
Intelerad Medical Systems: Salary (Ongoing) (employee) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Kallifatidis |
Alexandros |
Moderator, Speaker |
Bayer Hellas: Consulting Fees (e.g., advisory boards) (Ongoing)|Bayer Hellas: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|GE Healthcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Siemens Healthineers: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Khalique |
Omar |
Moderator |
Cardiac Implants: Consulting Fees (e.g., advisory boards) (Ongoing)|Croivalve: Consulting Fees (e.g., advisory boards) (Ongoing)|Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)|Restore medical: Consulting Fees (e.g., advisory boards) (Ongoing)|Triflo: Stock options (privately held) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Kim |
Raymond |
Speaker |
Boehringer Ingelheim: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Kottler |
Nina |
Speaker |
aidoc medical: my practice, Radiology Partners, has a limited interest in aidoc. I personally do not. (Ongoing)|Rad AI: my practice, Radiology Partners, has a very limited interest in Rad AI. I personally do not. (Ongoing)|Radiology Partners: employee, friendly physician for some sites, and physician partner - this is my primary employer (Ongoing)|Radiology Partners: Salary (Ongoing)|Synapsica Healthcare: I serve as an advisor and have unvested equity - however I am not discussing this company or their products (Ongoing)|W.L. Gore and Associates: Consulting Fees (e.g., advisory boards) (Terminated, January 9, 2023) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Kusmirek |
Joanna |
Moderator |
Bayer: Consulting Fees (e.g., advisory boards) (Terminated, September 30, 2022) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Lamb |
Hildo |
Speaker |
Royal Philips: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Larson |
Peder |
Moderator |
GE Healthcare: Research Support (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Lee |
Daniel |
Moderator Primary Author |
Abbott Labs, Inc.: Research Grant (Terminated, December 31, 2022)|Takeda: Salary (Terminated, June 11, 2021) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Leung |
Steve |
Speaker |
Siemens: Research Sequences, no money exchanged |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Lima |
Joao |
Moderator |
Astra Zeneca Pharmaceuticals: Grant support only (Ongoing)| Canon Medical Systems: Grant support only (Ongoing)|Toshiba Medical Systems: Grant support only (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Litt |
Harold |
Speaker |
Philips Healthcare: grant funding to my institution (Ongoing)|Philips Healthcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Siemens Healthineers: grant funding to my institution, travel support (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Manisty |
Charlotte |
Moderator, Presenting Author, Speaker |
MycardiumAI: Stock-privately held company |Pfizer: Consulting Fees (e.g., advisory boards) |Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Manning |
Warren |
Moderator |
Siemens Healthineers: Research funding (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Markl |
Mark |
Speaker |
Circle Cardiovascular Imaging: Grant support (Ongoing)|Siemens: Grant support (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Marrouche |
Nassir |
Speaker |
Atricure: Consulting Fees (e.g., advisory boards) (Ongoing)|Biosense Webster: Consulting Fees (e.g., advisory boards) (Ongoing)|Biosense Webster: Research (Ongoing)|Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|BMS: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Boston Scientific: Research (Ongoing)|JNJ: Research (Ongoing)|Medtronic: Research (Ongoing)|Pfizer: Consulting Fees (e.g., advisory boards) (Ongoing)|Sanofi: Consulting Fees (e.g., advisory boards) (Ongoing)|Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|St Jude: Research (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Masci |
Pier-Giorgio |
Speaker |
Perspectum Diagnostics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Masri |
Ahmad |
Speaker |
Attralus: Consulting Fees (e.g., advisory boards) (Ongoing)|BMS: Consulting Fees (e.g., advisory boards) (Ongoing)|Cytokinetics: Consulting Fees (e.g., advisory boards) (Ongoing)|Eidos Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing)|intellia: Consulting Fees (e.g., advisory boards) (Ongoing)|Ionis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing)|Pfizer: Consulting Fees (e.g., advisory boards) (Ongoing)|Tenaya Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Meyer |
Craig |
Moderator, Speaker |
Siemens Medical Solutions USA, Inc.: Research Grant (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Miller |
Christopher |
Speaker |
AstraZeneca: Consulting Fees (e.g., advisory boards) (Terminated, October 10, 2022)|AstraZeneca: Conference attendance (Terminated, October 10, 2022)|Boehringer Ingelheim: Consulting Fees (e.g., advisory boards) (Terminated, November 14, 2022)|Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 14, 2022) |Guerbet Laboratories Limited: Research grant (Ongoing)|Haya Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing)|Novo Nordisk: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 25, 2022) |PureTech Health: Consulting Fees (e.g., advisory boards) (Terminated, December 8, 2021)|Univar Solutions B.V.: Research support in kind (Investigational medicinal product) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Moon |
James |
Speaker, Moderator |
Mycardium ai ltd: Founder, investor, shareholder - ongoing |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Neubauer |
Stefan |
Moderator, Presenting Author, Speaker |
Caristo Diagnostics: Consulting Fees (e.g., advisory boards) (Ongoing)|Caristo Diagnostics: Non-executive director, stock owner (Ongoing)|Cytokinetics: Grant funding for HCMR study to University of Virginia (Ongoing)|Perspectum: Stock owner (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Nezafat |
Reza |
Speaker |
Siemens |
Researcher through Harvard Medical Faculty Physicians @ Beth Israel Deaconess Medical Center |
|
|
Ng |
Ming- Yen |
Speaker |
Arterys: Education Grant (Ongoing)|Bayer: Education Grant (Ongoing)|Circle Cardiovascular Imaging: Education Grant (Ongoing)|Circle Cardiovascular Imaging: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Lode: Education Grant (Ongoing)|TeraRecon: Education Grant (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Nijveldt |
Robin |
Moderator |
Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated) |Biotronik: Unrestricted research grant to the hospital (Ongoing)|BMS: Consulting Fees (e.g., advisory boards) (Ongoing)|BMS: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Philips Volcano: Unrestricted research grant to the hospital (Ongoing)|Sanofi-Genzyme: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Nordbeck |
Peter |
Speaker |
Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing)|Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Amicus Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing)|Amicus Therapeutics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)|Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Cardiac Dimensions: Consulting Fees (e.g., advisory boards) (Ongoing)|Cardiac Dimensions: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Chiesi: Consulting Fees (e.g., advisory boards) (Ongoing)|Chiesi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Idorsia: Consulting Fees (e.g., advisory boards) (Ongoing)|Sanofi-Genzyme: Consulting Fees (e.g., advisory boards) (Ongoing)|Sanofi-Genzyme: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Takeda: Consulting Fees (e.g., advisory boards) (Ongoing)|Takeda: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Nyktari |
Evangelia |
Presenting Author, Speaker |
Bayer: Consulting Fees (e.g., advisory boards) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Parwani |
Purvi |
Speaker |
AstraZeneca: Consulting Fees (e.g., advisory boards) (Ongoing)|AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Patel |
Amit |
Moderator, Speaker, Speaker |
Arterys: RESEARCH SUPPORT (Ongoing)|Circle CVI: RESEARCH SUPPORT (Ongoing)|General Electric: RESEARCH GRANT (Terminated)|neosoft: RESEARCH SUPPORT (Ongoing)|Siemens Healthineers: RESEARCH SUPPORT (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Raimondi |
Francesca |
Moderator, Speaker |
ATAMYO: Consulting Fees (e.g., advisory boards) (Terminated, December 31, 2022) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Redheuil |
Alban |
Speaker |
Imageens: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Robinson |
Joshua |
Panelist, Speaker |
Doximity, Inc: Stock-publicly held company (excluding mutual/index funds) (Ongoing)|Siemens Medical Solutions USA. Inc: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Salerno |
Michael |
Moderator |
GE Healthcare: Research Grant Support (Ongoing)|Siemens Healthineers: Research Support (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Schelbert |
Erik |
Speaker |
Haya Therapeutics: Scientific Advisory Board (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Schulz-Menger |
Jeanette |
Speaker |
circle institute: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Seiberlich |
Nicole |
Speaker |
Siemens Healthineers: research support (Ongoing)|Siemens Healthineers: Royalty (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Shah |
Dipan |
Moderator |
Guerbet: Research Funding (Only list those where you are the PI) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Simonetti |
Orlando |
Moderator, Speaker |
CALYX: Consulting Fees (e.g., advisory boards) (Ongoing)|Cook Medical: Institutional research support (Ongoing)|Myocardial Solutions: Institutional research grant (Ongoing)|Nano4Imaging: Institutional research support (Ongoing)|Siemens Medical Solutions USA, Inc.: Institutional research grant (Ongoing)|Siemens Medical Solutions USA, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Sinusas |
Albert |
Speaker |
Jubilant: grant support (Ongoing)|Lantheus: material transfer agreement (Ongoing)|MicroVide, LLC: Limited partner (Ongoing)|MostCardio, LLC: Consulting Fees (e.g., advisory boards) (Ongoing)|Siemens Healthcare: grant support (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Slomka |
Piotr |
Speaker |
Cedars-Sinai: Royalty (Ongoing)|Siemens Healthcare: grant support (Terminated, June 30, 2022)|Synektik: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Spincemaille |
Pascal |
Moderator |
Cornell University: Intellectual Property (Ongoing)|MedImageMetric: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Tandon |
Animesh (Aashoo) |
Panelist, Speaker |
NVIDIA: Stock-publicly held company (excluding mutual/index funds) (Ongoing)|Realize Medical: Consulting Fees (e.g., advisory boards) (Ongoing)|Siemens Healthineers: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Treibel |
Thomas |
Moderator, Speaker |
Mycardium ai ltd: Stock-publicly held company (excluding mutual/index funds) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Ugander |
Martin |
Moderator, Speaker |
Siemens: Non-financial institutional research agreement (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Valente |
Anne Marie |
Moderator |
American College of Cardiology: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)|Elsevier: Consulting Fees (e.g., advisory boards) (Ongoing)|UP to date: Royalty (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Wei |
Janet |
Speaker |
Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Weinsaft |
Jonathan |
Moderator |
General Electric: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Weissman |
Gaby |
Moderator |
Abbott: Research support for core lab (Ongoing)|Ancora: Research support for core lab (Ongoing)|Boston Scientific: Research support for core lab (Ongoing)|Medtronic: Research support for core lab (Ongoing)|NeoVasc: Research support for core lab (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Westwood |
Mark |
Moderator |
MyocardiumAI: I am a founding director and shareholder for this corelab company (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
White |
James |
Moderator |
Circle Cardiovascular Imaging: Research funding (Ongoing)|Cohesic Inc.: Shares (Ongoing)|Pfizer: Research funding (Ongoing)|Siemens Healthineers: Research funding (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Wong |
Timothy |
Speaker |
Bristol Myers Squibb: Site Principal Investigator for mavacamten clinical trials; unpaid advisory board participation (Ongoing)|Cytokinetics: Site Principal Investigator for aficamten clinical trials; unpaid advisory board participation (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Wood |
John |
Moderator |
AGIOS: Consulting Fees (e.g., advisory boards) (Ongoing)|Celgene: Consulting Fees (e.g., advisory boards) (Ongoing)|Imago Biosciences: Consulting Fees (e.g., advisory boards) (Ongoing)|PHARMACOSMOS: Consulting Fees (e.g., advisory boards) (Ongoing)|Philips Healthcare: GRANT FUNDING & RESEARCH SUPPORT-IN-KIND (Ongoing)|Sanofi/Regeneron: Consulting Fees (e.g., advisory boards) (Ongoing)|VIFOR: Consulting Fees (e.g., advisory boards) (Ongoing)|World Care Clinical: Consulting Fees (e.g., advisory boards) (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Wright |
Graham |
Speaker |
GE Healthcare: Research Support (Ongoing)|Siemens Healthineers: Research Support (Ongoing)|Vista.ai: Research Support (Ongoing) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
|
Zimmerman |
Stefan |
Speaker |
Bayer Healtcare: Research support (Ongoing)|Siemens Healthcare: partial salary support for consulting (Terminated, July 1, 2021) |
Provided attestation to comply Standards for Integrity and Independence in Accredited Continuing Education |
|
PLANNER/REVIEWER DISCLOSURES
The following planners for this CME activity who served have indicated that they do have financial relationships with ACCME defined ineligible companies within the past 24 months. All financial relationships have been mitigated. No Employees or Owners of ACCCME defined ineligible companies served in this capacity relative to the development of the content of this program. Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed.
All others in control of content (as planners or reviewers) not listed below have indicated that they have no financial relationships to disclose. All financial relationships have been mitigated.
|
Last Name |
First Name |
Role |
Financial Disclosure |
Method of Mitigation |
|
Allen |
Bradley |
Reviewer |
Circle Cardiovascular Imaging: Consulting Fees (E.G., Advisory Boards) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Al-Mallah |
Mouaz |
Reviewer |
Jubilant: Speaker/Honoraria (Includes Speakers Bureau, Symposia, And Expert Witness)|Siemens: Research Funding |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Coelho-Filho |
Otavio |
Planner |
Dr. Coelho-Filho has received research grant from Pfizer and has received speaking honoraria from Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Novartis, Takeda, and Pfizer. |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Ennis |
Daniel |
Planner/Reviewer |
GEHealthcare and Siemens.: Research Funding |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Han |
Yuchi |
Planner |
Speaker’s bureau for GE, and receives consultation fees from Vertex |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Hanneman |
Kate |
Planner |
Receives honoraria from Sanofi-Genzyme and Amicus. |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Kramer |
Christopher |
Reviewer |
Bms: Consulting Fees (E.G., Advisory Boards)|Bms: Research Funding |Cytokinetics: Research Funding |Eli Lilly: Consulting Fees (E.G., Advisory Boards)|Eli Lilly: Research Funding |Xencor: Consulting Fees (E.G., Advisory Boards) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Kusmirek |
Joanna |
Planner/Reviewer |
Bayer: Consulting Fees (E.G., Advisory Boards) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Lamb |
Hildo |
Planner/Reviewer |
Royal Philips: Consulting Fees (E.G., Advisory Boards) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Lederman |
Robert |
Planner |
Investigator for a CRADA (Cooperative Research Development Agreement) between NIH and Siemens |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Leung |
Steve |
Planner/Reviewer |
Siemens: Research Sequences, No Money Exchanged |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Leiner |
Tim |
Planner |
Pie Medical BV – Research Support, Cart-Tech – Advisory Board & AI4Med, Quantib – Clinical Advisor, Guerbet - Consultant |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Manisty |
Charlotte |
Reviewer |
Mycardiumai: Stock-Privately Held Company|Pfizer: Consulting Fees (E.G., Advisory Boards)|Pfizer: Speaker/Honoraria (Includes Speakers Bureau, Symposia, And Expert Witness) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Manka |
Robert |
Planner |
Advisory board for, and receives speaker fees from Bayer AG |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Masri |
Ahmad |
Reviewer |
Eidos, Pfizer, Ionis, Bms, Attralus, Tenaya, Alnylam And Cytokinetics: Consulting Fees (E.G., Advisory Boards)|Eidos, Pfizer, Ionis, Bms, Attralus, Tenaya, Alnylam And Cytokinetics: Speaker/Honoraria (Includes Speakers Bureau, Symposia, And Expert Witness)|Pfizer, Akcea, Ionis, Ultromics: Research Funding |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Nickander |
Jannike |
Reviewer |
Sanofi Genzyme: Speaker/Honoraria (Includes Speakers Bureau, Symposia, And Expert Witness) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Patel |
Amit |
Planner |
Research grants from General Electric and Philips |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Petersen |
Steffen |
Reviewer |
Circle Cardiovascular Imaging, Inc: Consulting Fees (E.G., Advisory Boards) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Salerno |
Michael |
Planner |
Siemens Healthineers - Research Support (Non-financial) GE Healthcare - Research Grant |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Schulz-Menger |
Jeanette |
Reviewer |
Circle Institute: Speaker/Honoraria (Includes Speakers Bureau, Symposia, And Expert Witness) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Schwitter |
Juerg |
Reviewer |
Bayer Healthcare: Research Funding |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Shah |
Dipan |
Planner/Reviewer |
Guerbet: Research Funding |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Sierra-Galan |
Lilia |
Planner |
Speaker fees from Pfizer, and research support and travel/meeting support from AMGEN |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Subramanian |
Sharath |
Reviewer |
Amgen: Speaker/Honoraria (Includes Speakers Bureau, Symposia, And Expert Witness) |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Ugander |
Martin |
Reviewer |
Siemens: Research Support In Kind |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Vucic |
Esad |
Reviewer |
Dyad Medical: Stock-Privately Held Company |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Westwood |
Mark |
Reviewer |
Mycardium Ai: Stock-Privately Held Company |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Wieben |
Oliver |
Reviewer |
Ge Healthcare: Research Funding |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |
|
Wolff |
Steven |
Reviewer |
Neosoft: Owner |
Those with declared relationships who are not employees or owners of ineligible companies were mitigated by ensuring that other members of the planning committee teamed with them to ensure content is free from bias and/or products services of entities were disclosed. |